Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ahuja

Showing results (351-360 of 662) with videos related to

Pageof 67
Sort By:
Biochemical Genetics|April 15, 2010
AFLP-based genetic diversity assessment of commercially important tea germplasm in IndiaR K Sharma, M S Negi, S Sharma, et al.
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
The Journal of Allergy and Clinical Immunology|September 24, 2016
Preservation of epithelial cell barrier function and muted inflammation in resistance to allergic rhinoconjunctivitis from house dust mite challengeSunil K Ahuja, Muthu Saravanan Manoharan, Nathan L Harper, et al.
Physiological Genomics|February 3, 2005
Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American populationMohammed S Orloff, Sudha K Iyengar, Cheryl A Winkler, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypesE Gonzalez, M Bamshad, N Sato, et al.
Science (New York, N.Y.)|January 8, 2005
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibilityEnrique Gonzalez, Hemant Kulkarni, Hector Bolivar, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2007
NPHS2 variation in sporadic focal segmental glomerulosclerosisLouise M McKenzie, Sher L Hendrickson, William A Briggs, et al.
Journal of the American Society of Nephrology : JASN|October 15, 2011
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathyJeffrey B Kopp, George W Nelson, Karmini Sampath, et al.
Nature Genetics|September 17, 2008
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisJeffrey B Kopp, Michael W Smith, George W Nelson, et al.
Nature Immunology|October 24, 2007
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanismsMatthew J Dolan, Hemant Kulkarni, Jose F Camargo, et al.
Pageof 67

Showing results (351-360 of 662) with videos related to

Sort By:
Pageof 67
Biochemical Genetics|April 15, 2010
AFLP-based genetic diversity assessment of commercially important tea germplasm in IndiaR K Sharma, M S Negi, S Sharma, et al.
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
The Journal of Allergy and Clinical Immunology|September 24, 2016
Preservation of epithelial cell barrier function and muted inflammation in resistance to allergic rhinoconjunctivitis from house dust mite challengeSunil K Ahuja, Muthu Saravanan Manoharan, Nathan L Harper, et al.
Physiological Genomics|February 3, 2005
Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American populationMohammed S Orloff, Sudha K Iyengar, Cheryl A Winkler, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypesE Gonzalez, M Bamshad, N Sato, et al.
Science (New York, N.Y.)|January 8, 2005
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibilityEnrique Gonzalez, Hemant Kulkarni, Hector Bolivar, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2007
NPHS2 variation in sporadic focal segmental glomerulosclerosisLouise M McKenzie, Sher L Hendrickson, William A Briggs, et al.
Journal of the American Society of Nephrology : JASN|October 15, 2011
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathyJeffrey B Kopp, George W Nelson, Karmini Sampath, et al.
Nature Genetics|September 17, 2008
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisJeffrey B Kopp, Michael W Smith, George W Nelson, et al.
Nature Immunology|October 24, 2007
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanismsMatthew J Dolan, Hemant Kulkarni, Jose F Camargo, et al.
Pageof 67